SGLT2 Inhibitors Reduce Anemia Risk in Concomitant T2D, CKD ...Middle East

Initiating treatment with SGLT2 inhibitors vs GLP-1 RAs was linked to a 19% reduced risk for composite anemia outcomes in patients with T2D and CKD stages I-III. Medscape Medical News

Hence then, the article about sglt2 inhibitors reduce anemia risk in concomitant t2d ckd was published today ( Thursday 11/04/2024 - 02:08 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( SGLT2 Inhibitors Reduce Anemia Risk in Concomitant T2D, CKD )

Also on site :

• 1998 ‘Days of Our Lives’ Departure Ended a Record-Breaking Run of Six Distinct Roles That Changed Daytime TV Forever
• Dijo que las Fuerzas Armadas debían estar compuestas por “machos y hembras alfa”. Hoy es el secretario interino de la Marina
• Empresas pagan hasta US$ 4 millones para cruzar el canal de Panamá tras el bloqueo en el estrecho de Ormuz